Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nozinan versus dexamethasone + metoclopramide for delayed chemotherapy-induced emesis
ISRCTN96357650Phase 2Completed
- Sponsor
- United States Department of Health and Human Services
- Start
- Sep 2000
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 2, randomised trial of levomepromazine, dexamethasone and metoclopramide in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by United States Department of Health and Human Services. Primary endpoint: Reduction in emesis. Started Sep 2000; status: completed.
02
Drugs
levomepromazinedexamethasonemetoclopramide
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on ISRCTN96357650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN96357650.